Different substitutions at the same β-myosin residue underlie divergent molecular phenotypes and distinct cardiomyopathies
5 affiliations
- 1Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado, USA
- 2Department of Biochemistry and Molecular Biophysics, Washington University in St Louis, St Louis, Missouri, USA
- 3Medical Scientist Training Program, Washington University in St Louis, St Louis, Missouri, USA
- 4Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- 5Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, USA
Abstract
In genetic cardiomyopathies, a frequently described phenomenon is how similar mutations in one protein can lead to discrete clinical phenotypes. One example is illustrated by two mutations in beta myosin heavy chain (MYH7) that are linked to hypertrophic cardiomyopathy (HCM) (Ile467Val, I467V) and left ventricular noncompaction (LVNC) (Ile467Thr, I467T). To investigate how these missense mutations lead to independent diseases, we studied the molecular effects of each mutation using recombinant human MYH7 Subfragment 1 (S1) in in vitro assays. Both HCM-I467V and LVNC-I467T S1 mutations exhibited similar mechanochemical functions, including unchanged actin-activated maximal ATPase and enhanced actin velocity. Molecular dynamics simulations revealed that both I467T and I467V allosterically disrupt interactions between myosin and ADP, which may contribute to the enhanced actin velocity observed in these mutations. However, I467V and I467T had distinct effects on the single turnover rate of myosin. HCM-I467V S1 showed no change in single ATP turnover rate, while LVNC-I467T reduced the single turnover rate by 50%. These contrasting molecular effects may lead to contractile dysregulation that initiates LVNC-associated signaling pathways that progress the phenotype. Taken together, our results suggest that phenotypic complexity likely originates at the biochemical level.
Related
- Patient-Derived hiPSC-Cardiomyocytes and Engineered Heart Tissues Reveal Distinct Functional Phenotypes in Inherited Cardiomyopathies
- Delayed menopausal transition in polycystic ovary syndrome: A call for research on age‐dependent phenotypes and different ethnic populations
- Shared mediators, divergent networks: a tissue-response hypothesis for discordant phenotypes in chronic spontaneous urticaria and atopic dermatitis
- The Same, but Different: Shared Hallmarks and Divergent Drivers in Adult, Pediatric and Canine Glioma.
- A multifunctional PKS-NRPS megasynthetase in nematodes produces divergent signaling molecules that control different developmental arrests.
BibTeX
@article{lehman2026different,
title = {{Different substitutions at the same β-myosin residue underlie divergent molecular phenotypes and distinct cardiomyopathies}},
author = {Sarah J. Lehman and Artur Meller and Shahlo O. Solieva and Jeffrey M. Lotthammer and Lina Greenberg and Stephen J. Langer and Michael J. Greenberg and Jil C. Tardiff and Gregory R. Bowman and Leslie Leinwand},
journal = {The Journal of Biological Chemistry},
year = {2026},
month = sep,
doi = {10.1016/j.jbc.2026.113585},
url = {https://doi.org/10.1016/j.jbc.2026.113585},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Different substitutions at the same β-myosin residue underlie divergent molecular phenotypes and distinct cardiomyopathies
AU - Sarah J. Lehman
AU - Artur Meller
AU - Shahlo O. Solieva
AU - Jeffrey M. Lotthammer
AU - Lina Greenberg
AU - Stephen J. Langer
AU - Michael J. Greenberg
AU - Jil C. Tardiff
AU - Gregory R. Bowman
AU - Leslie Leinwand
PY - 2026
DA - 2026/09/23
JO - The Journal of Biological Chemistry
DO - 10.1016/j.jbc.2026.113585
UR - https://doi.org/10.1016/j.jbc.2026.113585
AB - In genetic cardiomyopathies, a frequently described phenomenon is how similar mutations in one protein can lead to discrete clinical phenotypes. One example is illustrated by two mutations in beta myosin heavy chain (MYH7) that are linked to hypertrophic cardiomyopathy (HCM) (Ile467Val, I467V) and left ventricular noncompaction (LVNC) (Ile467Thr, I467T). To investigate how these missense mutations lead to independent diseases, we studied the molecular effects of each mutation using recombinant human MYH7 Subfragment 1 (S1) in in vitro assays. Both HCM-I467V and LVNC-I467T S1 mutations exhibited similar mechanochemical functions, including unchanged actin-activated maximal ATPase and enhanced actin velocity. Molecular dynamics simulations revealed that both I467T and I467V allosterically disrupt interactions between myosin and ADP, which may contribute to the enhanced actin velocity observed in these mutations. However, I467V and I467T had distinct effects on the single turnover rate of myosin. HCM-I467V S1 showed no change in single ATP turnover rate, while LVNC-I467T reduced the single turnover rate by 50%. These contrasting molecular effects may lead to contractile dysregulation that initiates LVNC-associated signaling pathways that progress the phenotype. Taken together, our results suggest that phenotypic complexity likely originates at the biochemical level.
SN - 0021-9258
SN - 1083-351X
ER -